Selegiline
Links shared publicly online about this topic
AAN 2011: Novel Selegiline Delivery Can Inhibit Brain MAO-A with Lower Tyramine Risk -- Implications for Parkinson's Disease
hcplive.com — “Selegiline inhibits MAO-A in the brain of patients with Parkinson's Disease without elevating the risk of hypertensive crisis from dietary tyramine.” View full resource at hcplive.com
Most Recently Shared on April 14, 2011 at 2:20 pm By:
#AAN2011 #selegiline inhibits MAO-A in brain of patients with #PD without raising risk of hypertension from tyramine http://hcp.lv/hSRQKp
ScienceDirect - Journal of Molecular Biology : The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of α-Synuclein Aggregation Leading to the Formation of Nontoxic Species
sciencedirect.com — “ScienceDirect - Journal of Molecular Biology : The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of α-Synuclein Aggregation Leading to the Formation of Nontoxic Species” View full resource at sciencedirect.com
Most Recently Shared on November 8, 2010 at 7:59 am By:
Selegiline delays alpha-synuclein aggregation and may slow down Lewy body formation in Parkinson's. http://tinyurl.com/32pyy7e
Psychiatry Medical News about Electroconvulsive Therapy
mdlinx.com — “Transdermal Selegiline in Patients Receiving Electroconvulsive Therapy” View full resource at mdlinx.com
Most Recently Shared on March 25, 2010 at 11:05 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Transdermal Selegiline in Patients Receiving Electroconvulsive Therapy: Psychosomatics http://bit.ly/bqLdyX #PSY
Psychiatry Medical News about Nicotine
mdlinx.com — “A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers” View full resource at mdlinx.com
Most Recently Shared on February 9, 2010 at 6:02 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Psych: A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking ... http://bit.ly/b6eqll
Monoamine Oxidase Type B Inhibitors in the Treatment of Early Parkinson's Disease | Neurology
touchneurology.com — “Parkinson's disease, monoamine oxidase type B (MAO-B) inhibitors, rasagiline, selegiline, Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) study, Rasagiline Mesylate (TVP-1012) in Early Monotherapy for PD Outpatients (TEMPO)” View full resource at touchneurology.com
Most Recently Shared on October 24, 2010 at 12:15 pm By:
touchNEURO Health Site and Neurology
Monoamine Oxidase Type B treatment - http://ow.ly/2V5ab
Antidepressant patch doesn't help smokers quit
health.yahoo.net — “An antidepressant drug delivered through a patch on the skin is no better than placebo for helping smokers kick the habit, new research shows.” View full resource at health.yahoo.net
Most Recently Shared on September 3, 2010 at 10:40 pm By:
Antidepressant patch doesn't help smokers quit http://bit.ly/9x3fHS
Antidepressant patch doesn't help smokers quit http://ow.ly/18Ro0W
reuters.com — “Antidepressant patch doesn't help smokers quit http://ow.ly/18Ro0W” View full resource at reuters.com
Most Recently Shared on September 4, 2010 at 3:22 am By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
Antidepressant patch doesn't help smokers quit http://ow.ly/18Ro0W
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
HCPLive
Your online destination for Neurology news,events,and resources
-
Kieran Breen
Director of Research at Parkinson's UK (@ParkinsonsUK)
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
